Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • Delayed-onset and long-lasting...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

Delayed-onset and long-lasting severe neutropenia due to rituximab

Bibliographic Details
Published in:Swiss Medical Weekly
Main Author: Swiss Medical Weekly
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2004-02-01
Subjects:
Burkitt's lymphoma
Hypogammaglobulinaemia
neutropenia
Mabthera
rituximab
Online Access:https://www.smw.ch/index.php/smw/article/view/342
  • Holdings
  • Description
  • Similar Items
  • Staff View
Description
ISSN:1424-3997

Similar Items

  • THE EFFICACY AND SAFETY OF RITUXIMAB BIOSIMILAR (ACELLBIA®) IN RHEUMATOID ARTHRITIS AS THE FIRST BIOLOGICAL AGENT: RESULTS OF PHASE III (ALTERRA) CLINICAL TRIAL
    by: E. L. Nasonov, et al.
    Published: (2017-09-01)
  • A Retrospective Analysis of Rituximab Treatment for B Cell Depletion in Different Pediatric Indications
    by: Merlin Wennmann, et al.
    Published: (2021-11-01)
  • Treatment of B-cells non-Hodgkin lymphomas with combined immunochemotherapy: ability to treatment optimization
    by: N. V. Smirnova, et al.
    Published: (2015-12-01)
  • Efficacy and safety of rituximab-based chemoimmunotherapy in adult patients with Burkitt lymphoma in Korea
    by: Gi-June Min, et al.
    Published: (2025-07-01)
  • An update on the incidence, risk factors and mechanisms of rituximab-associated neutropenia
    by: Xuehan Zhang, et al.
    Published: (2022-09-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs